ticagrelor has been researched along with Glioblastoma* in 1 studies
1 other study(ies) available for ticagrelor and Glioblastoma
| Article | Year |
|---|---|
P2Y
Glioblastoma (GBM) is the most aggressive and lethal among the primary brain tumors, with a low survival rate and resistance to radio and chemotherapy. The P2Y Topics: Adenosine Diphosphate; Autophagy; Blood Platelets; Cell Proliferation; Glioblastoma; Humans; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor | 2022 |